Influence of formulation variables in transdermal drug delivery system containing zolmitriptan

被引:32
|
作者
Subedi, Robhash Kusam [1 ]
Ryoo, Je-Phil
Moon, Cheol
Choi, Hoo-Kyun [1 ]
机构
[1] Chosun Univ, Coll Pharm, Project Team BK21, Kwangju 501759, South Korea
关键词
Zolmitriptan; Transdermal drug delivery; Percutaneous penetration; Chemical enhancers; Polymorphism; Crystallization inhibitor; CRYSTALLIZATION; PERMEATION; ADHESIVES; ENHANCERS; MATRIX; SKIN;
D O I
10.1016/j.ijpharm.2011.08.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of different formulation variables including pressure sensitive adhesive (PSA), thickness of the matrix, solvent system, inclusion of crystallization inhibitor, loading amount of drug and enhancers on the transdermal absorption of zolmitriptan were investigated. Acrylic adhesive with hydroxyl functional group provided good adhesion force and high flux of zolmitriptan. Pseudopolymorphs of zolmitriptan were found to possess different solid-state properties that affected the permeation rate. Polyoxyethylene alkyl ethers significantly increased the permeation of zolmitriptan through hairless mouse skin. However, these enhancers induced crystallization of zolmitriptan. Kollidon (R) 30 delayed the crystallization without altering the permeation profile of zolmitriptan. Stability studies suggested that terpenes did not induce crystallization of zolmitriptan in the patch and stable formulations could be produced by using cineole and limonene, or their combination. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:209 / 214
页数:6
相关论文
共 50 条
  • [1] Influence of different formulation variables on the performance of transdermal drug delivery system containing tizanidine hydrochloride: in vitro and ex vivo evaluations
    Shabbir, Maryam
    Ali, Sajid
    Hamid, Irfan
    Sharif, Ali
    Akhtar, Muhammad Furqan
    Raza, Moosa
    Ahmed, Shoaib
    Peerzada, Sohaib
    Amin, Muhammad Umair
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 54 (04)
  • [2] Formulation and Evaluation of Transdermal Drug Delivery System Containing Lornoxicam.
    Prakash, Gorle Ashish
    Arun, Patil Mukesh
    RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 2016, 7 (03): : 2148 - 2157
  • [3] Formulation development of a transdermal drug delivery system for amlodipine base
    McDaid, DM
    Deasy, PB
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 133 (1-2) : 71 - 83
  • [4] A New Transdermal Drug Delivery System Containing Hydroquinone
    Bezerra, Simone S.
    de Deus, Dayse M. V.
    Alves, Tais V. G.
    Costa, Roseane M. R.
    Caetano, Maria N. P.
    Santos-Magalhaes, Nereide S.
    LATIN AMERICAN JOURNAL OF PHARMACY, 2011, 30 (09): : 1833 - 1842
  • [5] DESIGN, FORMULATION AND EVALUATION OF TRANSDERMAL DRUG DELIVERY SYSTEM OF BUDESONIDE
    Amgaokar, Yogesh M.
    Chikhale, Rupesh V.
    Lade, Updesh B.
    Biyani, Dinesh M.
    Umekar, Milind J.
    DIGEST JOURNAL OF NANOMATERIALS AND BIOSTRUCTURES, 2011, 6 (02) : 475 - 497
  • [6] Formulation and in vitro evaluation of transdermal drug delivery system for donepezil
    Robhash Kusam Subedi
    Je-Phil Ryoo
    Cheol Moon
    Myung-Kwan Chun
    Hoo-Kyun Choi
    Journal of Pharmaceutical Investigation, 2012, 42 (1) : 1 - 7
  • [8] Formulation and evaluation of transdermal drug-delivery system of isosorbide dinitrate
    Zhan, Xiaoping
    Mao, Zhenmin
    Chen, Sijing
    Chen, Shaoxiong
    Wang, Liqun
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 51 (02) : 373 - 382
  • [9] FORMULATION AND INVITRO EVALUATION OF GALANTAMINE PATCHES FOR TRANSDERMAL DRUG DELIVERY SYSTEM
    Likhitha, Chiramala
    Kishore, K.
    Kumar, Gampa Vijay
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (12): : 16576 - 16582
  • [10] Transdermal drug delivery: Vehicle design and formulation
    Pefile, S
    Smith, EW
    SOUTH AFRICAN JOURNAL OF SCIENCE, 1997, 93 (04) : 147 - 150